Insperity, Inc.
NSP NYSE Services-Help Supply Services Financials FY2016βFY2025
What Insperity, Inc. does
No business description yet.
- Legal name
- INSPERITY, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 11, 2026
- Accession Β· CIK
- 0001000753-26-000011
0001000753
Revenue and margins
Insperity, Inc. had $6.8B of revenue in fiscal 2025, up 3.5% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$309M in fiscal 2025, β4.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Insperity, Inc. returned $109M to shareholders in fiscal 2025. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Insperity, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $697M | $823M | $828M | $1.2B | $682M |
| Debt incl. finance leases | $369M | $369M | $369M | $369M | $369M |
| Net debt / EBITDA | β1.5x | β1.6x | β1.8x | β5.0x | β8.9x |
| Debt / equity | β | 4.6x | 3.9x | 3.8x | 8.0x |
| Interest coverage | 23.2x | 17.9x | 8.1x | 4.2x | β0.4x |
| Current ratio | 1.1x | 1.1x | 1.1x | 1.1x | 1.1x |
| Quick ratio | 1.1x | 1.1x | 1.1x | 1.1x | 1.1x |
| Total assets | $1.8B | $2.0B | $2.1B | $2.6B | $2.2B |
| Total liabilities | $1.8B | $2.0B | $2.0B | $2.5B | $2.2B |
| Shareholders' equity | β$2.0M | $81.0M | $94.0M | $97.0M | $46.0M |
| Net debt (β = net cash) | β$327M | β$454M | β$459M | β$803M | β$313M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 7 / 8 | 7 / 8 | 3 / 8 | 5 / 8 | 5 / 8 | 8 / 9 | 6 / 9 | 5 / 9 | 2 / 9 |
| Accruals ratio | β8.7% | β13.1% | β4.4% | β4.2% | β14.0% | β8.2% | β8.9% | β1.3% | β18.2% | 11.3% |
| Altman Z'' | 2.15 | 2.13 | 2.69 | 2.57 | 2.75 | 2.13 | 2.42 | 2.37 | 1.66 | 1.24 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $2.9B | $3.3B | $3.8B | $4.3B | $4.3B | $5.0B | $5.9B | $6.5B | $6.6B | $6.8B |
| Gross profit | $492M | $573M | $682M | $733M | $807M | $820M | $1.0B | $1.0B | $1.1B | $900M |
| Operating income | $106M | $130M | $179M | $187M | $195M | $173M | $250M | $219M | $117M | β$10.0M |
| Interest expense | $2.4M | $3.2M | $4.7M | $7.6M | $8.0M | $7.5M | $14.0M | $27.0M | $28.0M | $24.0M |
| Pretax income | $105M | $130M | $182M | $190M | $189M | $168M | $245M | $225M | $126M | β$4.0M |
| Income tax | $39.2M | $45.7M | $46.9M | $38.5M | $51.0M | $44.2M | $66.0M | $54.0M | $35.0M | $3.0M |
| Net income | $66.0M | $84.4M | $135M | $151M | $138M | $124M | $179M | $171M | $91.0M | β$7.0M |
| Net income to common | β | $82.9M | $134M | $149M | $137M | $124M | $179M | β | β | β |
| Diluted EPS | $1.54 | $2.01 | $3.22 | $3.70 | $3.54 | $3.18 | $4.64 | $4.47 | $2.42 | β$0.19 |
| Diluted shares | β | β | β | β | β | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B |
| Cash flow | ||||||||||
| Cash from operations | $145M | $213M | $184M | $205M | $346M | $260M | $347M | $198M | $520M | β$278M |
| Capital expenditure | $34.0M | $33.3M | $35.3M | $56.3M | $98.1M | $32.9M | $30.0M | $40.0M | $38.0M | $31.0M |
| Free cash flow | $111M | $180M | $149M | $149M | $248M | $227M | $317M | $158M | $482M | β$309M |
| Depreciation and amortization | $16.6M | $18.2M | $22.8M | $28.7M | $31.2M | $38.5M | $41.0M | $43.0M | $44.0M | $45.0M |
| Stock-based compensation | $16.6M | $24.3M | $20.4M | $24.0M | $60.1M | $40.6M | $50.0M | $53.0M | $61.0M | $61.0M |
| Share buybacks | $144M | $0.0M | $0.0M | β | β | $69.7M | $73.0M | $131M | $63.0M | $19.0M |
| Dividends paid | $20.6M | $65.8M | $33.4M | $48.6M | $61.9M | $144M | $77.0M | $84.0M | $89.0M | $90.0M |
| Dividends and buybacks | $165M | $65.8M | $33.4M | $48.6M | $61.9M | $214M | $150M | $215M | $152M | $109M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $288M | $379M | $404M | $415M | $637M | $697M | $823M | $828M | $1.2B | $682M |
| Total debt | $104M | $104M | $144M | $269M | $369M | $369M | $369M | $369M | $369M | $369M |
| Current assets | $640M | $779M | $867M | $975M | $1.1B | $1.2B | $1.5B | $1.6B | $2.1B | $1.7B |
| Current liabilities | $601M | $725M | $772M | $869M | $905M | $1.1B | $1.4B | $1.4B | $1.9B | $1.6B |
| Property and equipment, net | $80.3M | $95.7M | $117M | $148M | $216M | $211M | $200M | $197M | $192M | $177M |
| Goodwill | $12.7M | $12.7M | $12.7M | $12.7M | $12.7M | $12.7M | β | β | β | β |
| Total assets | $907M | $1.1B | $1.2B | $1.4B | $1.6B | $1.8B | $2.0B | $2.1B | $2.6B | $2.2B |
| Total liabilities | $847M | $997M | $1.1B | $1.4B | $1.5B | $1.8B | $2.0B | $2.0B | $2.5B | $2.2B |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $60.5M | $66.3M | $77.7M | $4.1M | $44.1M | β$2.0M | $81.0M | $94.0M | $97.0M | $46.0M |
| Margins | ||||||||||
| Gross margin | 16.7% | 17.4% | 17.8% | 17.0% | 18.8% | 16.5% | 17.0% | 16.0% | 16.0% | 13.2% |
| Operating margin | 3.6% | 3.9% | 4.7% | 4.3% | 4.5% | 3.5% | 4.2% | 3.4% | 1.8% | β0.1% |
| EBITDA margin | 4.2% | 4.5% | 5.3% | 5.0% | 5.3% | 4.3% | 4.9% | 4.0% | 2.4% | 0.5% |
| Net margin | 2.2% | 2.6% | 3.5% | 3.5% | 3.2% | 2.5% | 3.0% | 2.6% | 1.4% | β0.1% |
| FCF margin | 3.8% | 5.5% | 3.9% | 3.4% | 5.8% | 4.6% | 5.3% | 2.4% | 7.3% | β4.5% |
| Returns | ||||||||||
| Return on capital employed | 34.7% | 38.3% | 42.7% | 35.5% | 28.7% | 27.8% | 36.4% | 32.0% | 17.5% | β1.7% |
| Return on equity | 109.0% | 133.1% | 188.1% | 369.6% | 573.5% | 589.0% | 453.2% | 195.4% | 95.3% | β9.8% |
| Return on assets | 7.3% | 8.6% | 12.0% | 11.7% | 9.3% | 7.4% | 9.4% | 8.2% | 3.9% | β0.3% |
| Return on tangible equity | 137.9% | 154.5% | 205.5% | β | 437.3% | β | 221.4% | 181.9% | 93.8% | β15.2% |
| Growth | ||||||||||
| Revenue growth | β | 12.2% | 16.0% | 12.7% | β0.6% | 16.0% | 19.4% | 9.2% | 1.5% | 3.5% |
| Net income growth | β | 27.9% | 60.4% | 11.6% | β8.5% | β10.2% | 44.3% | β4.5% | β46.8% | β107.7% |
| EPS growth | β | 30.5% | 60.2% | 14.9% | β4.3% | β10.2% | 45.9% | β3.7% | β45.9% | β107.9% |
| FCF growth | β | 61.5% | β17.1% | β0.2% | 66.8% | β8.4% | 39.5% | β50.2% | 205.1% | β164.1% |
| Share count change | β | β | β | β | β | β | 0.3% | β2.6% | 0.0% | 0.0% |
| Financial health | ||||||||||
| Net debt / EBITDA | β1.5x | β1.9x | β1.3x | β0.7x | β1.2x | β1.5x | β1.6x | β1.8x | β5.0x | β8.9x |
| Debt / equity | 1.7x | 1.6x | 1.9x | 66.0x | 8.4x | β | 4.6x | 3.9x | 3.8x | 8.0x |
| Interest coverage | 44.4x | 40.4x | 38.4x | 24.4x | 24.3x | 23.2x | 17.9x | 8.1x | 4.2x | β0.4x |
| Current ratio | 1.1x | 1.1x | 1.1x | 1.1x | 1.2x | 1.1x | 1.1x | 1.1x | 1.1x | 1.1x |
| Quick ratio | 1.1x | 1.1x | 1.1x | 1.1x | 1.2x | 1.1x | 1.1x | 1.1x | 1.1x | 1.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.2% | 1.0% | 0.9% | 1.3% | 2.3% | 0.7% | 0.5% | 0.6% | 0.6% | 0.5% |
| Stock comp / revenue | 0.6% | 0.7% | 0.5% | 0.6% | 1.4% | 0.8% | 0.8% | 0.8% | 0.9% | 0.9% |
| Payouts / FCF | 148.0% | 36.6% | 22.4% | 32.7% | 24.9% | 94.1% | 47.3% | 136.1% | 31.5% | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 7.0 | 7.0 | 3.0 | 5.0 | 5.0 | 8.0 | 6.0 | 5.0 | 2.0 |
| Altman Z'' | 2.1 | 2.1 | 2.7 | 2.6 | 2.8 | 2.1 | 2.4 | 2.4 | 1.7 | 1.2 |
| Accruals ratio | β8.7% | β13.1% | β4.4% | β4.2% | β14.0% | β8.2% | β8.9% | β1.3% | β18.2% | 11.3% |
Source: SEC EDGAR XBRL filings (CIK 0001000753). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.